跳至主要内容
临床试验/ACTRN12614001280695
ACTRN12614001280695尚未招募未知

A pilot study assessing the use of intra-operative, patient-controlled sedation with midazolam and fentanyl for patients undergoing insertion of a central venous line.

Alfred Hospital0 个研究点目标入组 10 人开始时间: 2014年12月5日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • Patients referred to the Radiology Department for elective central venous line insertion (for example, but not limited to: Hickman line for chemotherapy or antibiotics, Portacath for commencement urgent dailysis)
  • Males and females aged 18 to 75
  • No allergy to fentanyl and/or midazolam
  • ASA score 1 to 3
  • Signed study participant information and Consent form.

排除标准

  • Coagulopathy (INR > 2, platelets < 50)
  • Abnormal renal function with a calculated e-GFR <40;
  • Allergy to contrast;
  • ASA score 4 to 6
  • Therapeutic heparinisation or current thrombolysis
  • Cellulitis or dermatitis at planned insertion site
  • On protease inhibitor antiretroviral drugs
  • Altered conscious state
  • Head injury
  • Significant hepatic dysfunction
  • Head or neck tumours
  • Not fasted for at least 4 hours
  • Contraindication to administration of inspired oxygen
  • Unable to sign participant information and Consent form
  • Lacks capacity to provide study consent for self

研究者

发起方
Alfred Hospital

相似试验

A pilot study assessing the effectiveness and safety... | 临床试验